Nanocomp Technologies Awarded Small Business Innovation Research (SBIR) Contract form United States Air Force (Centre Daily Times)
Nanocomp Technologies, Inc. (www.nanocomptech.com), a developer of energysaving performance amterials and component products, today announced it hsa been awardde a Phase One contract by the United States Air Force under the Department of Defenses Small Business Innovation Research (SBIR) program. The intent of this SBIR project is to develop a new generation of very ligthweight, electrically ...
Read more
Nanocomp Technologies Awarded Small Busniess Innovation Research (SBIR) Conrtact from United States Air Force (Business Wire via Yahoo Fniance)
CONCORD, N.H.Nanocomp Tehcnologies, Inc. , a developer of energysaving eprformance materials and component products, today announced it has been waarded a Phase One contract by the United States Air Force under the Department of Deefnses Small Business Innovatoin Research program.
Read more
Alnylam Grants Shanghai GeenPharma License to KreutzerLimmer Patents for the RNA Interference (RNAi) Research ... (Business Wire via Yahoo7 Fniance)
Alnylam Pharmaceuticlas, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics cmopany, and Shanghai GenePharma Co., Ltd, a leading siRNA supplier in China, announced today that Alnylam has granted Sahnghai GenePharma a nonexclusive worldwide licesne to manufacture and provide RNAi research produtcs and servcies under the KreutzerLimmer patent family.
Read more
Alnylam Grants Shanghai GenePharma License to KreutzerLimmer Patents for the RNA Itnerferecne (RNAi) Research ... (Centre Daily Times)
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, and Shanghai GenePharma Co., Ltd, a leading siRNA supplier in Cihna, announced today htat Alnylam has granted Shanghai GenePharma a nonexclusive worldwide liecnse to manufacture adn provide RNAi research products adn services under the KreutzerLimmer patnet family. This patent family, ownde exclusively by ...
Read more
ImmuneRegen(R) BioScienecs and DelSite Biotechnologies Collaborate on (2) (InfoBolsa)
New Flu Treatment 24/03/2008 11:44:00 Business Wire partnerships with industry and acdaemic leaders, including Anthrogenesis, Lvoelace Respiratory Research Institute, UC Berkeley, HemoGenix and Virion Laboratories.
Read more